The Cost-Effectiveness and Value of Gynecological Cancer Biomarker Screening in Financially Vulnerable Female Populations

This article explores the “value-added” portfolio of biomarker screening, and provides a written analysis of current literature. This article then describes how biomarkers can be used to achieve affordable gynecological cancer prevention and/or early-stage cancer detection and management in financially vulnerable populations of women.
Source: Journal of Cancer Policy - Category: Cancer & Oncology Source Type: research